MA
MEDP icon

Montag & Associates’s Medpace MEDP Stock Holding History

Montag & Associates’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2
Closed -$560 – 1139
2025
Q2 		$560 Sell
2
-1
-33% -$300 ﹤0.01% 934
2025
Q1 		$1.05K Buy
3
+1
+50% +$336 ﹤0.01% 947
2024
Q4 		$762 Hold
2
– – ﹤0.01% 975
2024
Q3 		$803 Hold
2
– – ﹤0.01% 996
2024
Q2 		$991 Hold
2
– – ﹤0.01% 935
2024
Q1 		$972 Buy
+2
New +$703 ﹤0.01% 930

Other funds holding MEDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Montag & Associates's MEDP Position: Q3 2025 in Review

Montag & Associates sold out of Medpace (MEDP) in Q3 2025, closing a stake of 2 shares — an estimated $560 sold.

Montag & Associates first reported a position in MEDP in Q1 2024 and held it in 6 quarters. The position peaked at $1.05K in Q1 2025. 672 funds tracked by Wall St. Rank hold MEDP as of Q3 2025.

  • Montag & Associates reported no remaining Medpace position as of Q3 2025 after selling out during the quarter.
  • Montag & Associates sold 2 Medpace shares in Q3 2025, an estimated $560.
  • Montag & Associates first reported a position in Medpace in Q1 2024 and held it in 6 quarters.
  • Montag & Associates's Medpace position peaked at $1.05K in Q1 2025.
  • 672 funds tracked by Wall St. Rank held Medpace as of Q3 2025.

Based on Montag & Associates's 13F filing for Q3 2025, filed 12 Nov 2025.